Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 27 Nov 2024

Estrogenized HSA induced high-affinity autoantibodies in breast cancer - Novel biomarker for early detection

in Cancer Molecular Targets and Therapeutics

Subuhi Sherwani
Mohd Wajid Ali Khan
Wahid Ali Khan
Saravanan Rajendrasozhan
Khalid Al-Motair
Hamda Khan
Saheem Ahmad

Frontiers in Oncology

doi 10.3389/fonc.2024.1493320

681 views

Original Research

Published on 26 Nov 2024

Comprehensive prognostic gene identification and functional characterization of GRAMD1A in Wilms tumor: development of risk prediction models and therapeutic implications

in Cancer Molecular Targets and Therapeutics

Qiang Zeng
Junfeng Tao
Lilu Qin
Yong Zeng
Zhong Liu
Mingxian Xu
Linshan Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1501718

965 views

Brief Research Report

Published on 26 Nov 2024

Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signaling

in Cancer Molecular Targets and Therapeutics

Ashley Patton
Natalie Horn
Puja Upadhaya
Patricia Sarchet
Raphael E. Pollock
Steve Oghumu
Obiajulu Hans Iwenofu

Frontiers in Oncology

doi 10.3389/fonc.2024.1456071

1,054 views

Systematic Review

Published on 25 Nov 2024

Potential urinary volatile organic compounds as screening markers in cancer – a review

in Cancer Molecular Targets and Therapeutics

Alexandre Goertzen
Biniam Kidane
Naseer Ahmed
Michel Aliani

Frontiers in Oncology

doi 10.3389/fonc.2024.1448760

1,975 views
2 citations

Original Research

Published on 22 Nov 2024

Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis

in Cancer Molecular Targets and Therapeutics

Ruyue Ma
Yu Zheng
Jianing Wang
Hong Xu
Ruirui Zhang
Zhijia Xie
Lei Zhang
Ruiheng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1387860

1,697 views

Original Research

Published on 22 Nov 2024

SLNP-based CDK4- targeted nanotherapy against glioblastoma

in Cancer Molecular Targets and Therapeutics

Uzma Ghani
Fareeha Khalid Ghori
Muhammad Usman Qamar
Hina Khan
Basit Azad
Sabahat Habib
Saira Justin
Ishaq N. Khan
Tawaf Ali Shah
Gamal A. Shazly

Frontiers in Oncology

doi 10.3389/fonc.2024.1455816

1,259 views

Review

Published on 21 Nov 2024

The effectiveness of acupuncture in cancer pain treatment

in Cancer Molecular Targets and Therapeutics

Kamila Krukowska
Sylwia Krzyśkowska
Eliza Kuchta
Anna Rudzińska
Katarzyna Szklener
Sławomir Mańdziuk

Frontiers in Oncology

doi 10.3389/fonc.2024.1450105

1,725 views

Systematic Review

Published on 20 Nov 2024

Clinicopathological significance and prognostic values of claudin18.2 expression in solid tumors: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Gyerim Park
Se Jun Park
Younghoon Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1453906

1,293 views

Case Report

Published on 19 Nov 2024

Invasive aspergillosis complicated in a patient with non-small cell lung cancer harboring RET fusion during treatment with RET-TKIs: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Kaidiriye Setiwalidi
Yimeng Li
Yuyan Ma
Zhanpeng Hao
Yujia Zhao
Yuxin Zhang
Xuan Liang
Tao Tian
Zhiping Ruan

Frontiers in Oncology

doi 10.3389/fonc.2024.1431908

1,180 views
1 citation

Case Report

Published on 18 Nov 2024

Bevacizumab for the treatment of metastatic colorectal cancer complicated by abdominal aortic aneurysm and mural thrombus: a case report

in Cancer Molecular Targets and Therapeutics

Yujun Li
Tong Wu
Muhammad Muddasar Saeed
Xiaonan Cui

Frontiers in Oncology

doi 10.3389/fonc.2024.1416349

1,051 views
1 citation

Original Research

Published on 15 Nov 2024

The role and mechanism of “eight famous herbals in Zhejiang” in cancer via network pharmacology and experimental validation

in Cancer Molecular Targets and Therapeutics

Ziheng Ni
Hao Zhang
Fengyun Chen
Mengjie Yang
Liting Yang
Yuan Zhou
Xianmin Zhou
Jiayi Guo
Xinyu Rao
Jiaqi Cen

Frontiers in Oncology

doi 10.3389/fonc.2024.1475000

1,088 views

Original Research

Published on 12 Nov 2024

Bone marrow mesenchymal stem cell-derived exosomes improve cancer drug delivery in human cell lines and a mouse osteosarcoma model

in Cancer Molecular Targets and Therapeutics

Wenquan Cai
Dawei He

Frontiers in Oncology

doi 10.3389/fonc.2024.1482087

1,181 views

Systematic Review

Published on 11 Nov 2024

The current state and trends of immunotherapy research in lung cancer: a review and bibliometric analysis

in Cancer Molecular Targets and Therapeutics

Yun-Hua Zheng
Li Chen
Xiang Liu
Rong-Hui Li
Hai-Bo Lei
Guang-Hui Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1428307

1,332 views

Original Research

Published on 08 Nov 2024

Characterization of the function and clinical value of ERCC family genes in lung adenocarcinoma

in Cancer Molecular Targets and Therapeutics

Zhimin Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1476100

686 views

Original Research

Published on 06 Nov 2024

Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study

in Cancer Molecular Targets and Therapeutics

Meiling Zhang
Li Wang
Qian Wang
Jiu Yang
Wei Peng
Xiaoyou Li
Meiqi Shi
Kaihua Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1441025

1,663 views

Case Report

Published on 28 Oct 2024

Response to furmonertinib in a patient with non-small cell lung cancer harboring HER2 exon 21 insertion mutation: a case report

in Cancer Molecular Targets and Therapeutics

Chunxiao Ni
Ling Zhang
Xin Yu
Yu Pang

Frontiers in Oncology

doi 10.3389/fonc.2024.1440379

1,248 views
1 citation